ASX 200 (XJO) morning report – Afterpay’s NASDAQ effect
The Australian share market, including the S&P/ASX 200 (ASX: XJO) and All Ordinaries (ASX: XAO), is expected to drop when the market opens this morning. Here’s what investors need to know.
The Australian share market, including the S&P/ASX 200 (ASX: XJO) and All Ordinaries (ASX: XAO), is expected to drop when the market opens this morning. Here’s what investors need to know.
The Australian share market, including the S&P/ASX 200 (ASX: XJO) and All Ordinaries (ASX: XAO), is set to bounce back today when the market opens.
The S&P/ASX 200 (XJO) and All Ordinaries (XAO) are set to follow US markets open this morning as Melbourne prepares to go back into lockdown.
The Australian share market, including the All Ordinaries Index (INDEXASX: XAO) and S&P/ASX 200 (INDEXASX: XJO) indices are expected to open slightly higher on Tuesday morning. Here’s what ETF investors need to know.
The Australian share market, including the All Ordinaries (INDEXASX: XAO) and ASX 200 (INDEXASX: XJO) are likely to open slightly lower on Monday, according to data from the Sydney Futures Exchange.
The S&P/ASX 200 (XJO) is expected to follow the lead of US markets and open higher on Friday. Here’s what you need to know.
The S&P/ASX 200 (XJO) is edging higher this morning as the market brushes aside COVID-19 concerns and continues its positive start to the new financial year.
Australia’s S&P/ASX 200 (XJO) and All Ordinaries (XAO) indices are tipped to jump at the open this morning. Infigen (ASX: IFN) and Qantas (ASX: QAN) shares are again the focal point.
The S&P/ASX 200 and All Ordinaries are likely to open in negative territory on Monday morning with Westpac (ASX:WBC), Saracen (ASX:SAR) and Virgin (ASX:VAH) in focus.
Australia’s ASX 200 and All Ordinaries index will rise this morning, according to the latest data out of the Sydney Futures Exchange.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024